mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |